Companies / Hungary
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Gedeon Richter Finding It Easier To Play Away From Home
May 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Hungarian drugmaker Gedeon Richter has posted its Q108 operating figures, demonstrating a 8.8% year-on-year (y-o-y) increase in sales to HUF57,026mn (US$352mn). Operating profit also increased, by 8.6% y-o-y to 10,096 (US$62.3mn), despite the addition of more than 1,300 staff in the past year. Profit was entirely attributable to Richter's pharmaceuticals division, with the wholesale sector making a loss of HUF339mn (US$2.1mn) in